Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapy

Lance K. Lassiter, Mohan K. Tummala, Maha H. Hussain, Walter M. Stadler, Daniel P. Petrylak, Michael A. Carducci

Research output: Contribution to journal › Article › peer-review

11 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II open-label study of oral piritrexim in patients with advanced carcinoma of the urothelium who have experienced failure with standard chemotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences